Global Epidemiology of HPV-Associated Recurrent Respiratory Papillomatosis and Effect of Vaccination

References

• Wierzbicka M , KlussmannJP, SanGiorgi MR, WuerdemannN, DikkersFG. Oral and laryngeal HPV infection: incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals. Vaccine, 39(17), 2344–2350 (2021).
   PubMed Web of Science ®Google Scholar
• Seedat RY . Juvenile-onset recurrent respiratory papillomatosis diagnosis and management – a developing country review. Pediatr. Health Med. Ther., 11, 39–46 (2020).
   PubMed Web of Science ®Google Scholar
• San Giorgi MRM , vanden Heuvel ER, TjonPian Gi REAet al. Age of onset of recurrent respiratory papillomatosis: a distribution analysis. Clin. Otolaryngol., 41(5), 448–453 (2016).
   PubMed Web of Science ®Google Scholar
• Seedat RY , SchallR. Age of diagnosis, incidence and prevalence of recurrent respiratory papillomatosis – a South African perspective. Clin. Otolaryngol., 43(2), 533–537 (2018).
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100B. A review of human carcinogens. Part B: Biological agents.International Agency for Research on Cancer, Lyon, France (2012).
   Google Scholar
• de Villiers EM , FauquetC, BrokerTR, BernardHU, zur HausenH. Classification of papillomaviruses. Virology, 324(1), 17–27 (2004).
   PubMed Web of Science ®Google Scholar
• Mühr LSA , EklundC, DillnerJ. Towards quality and order in human papillomavirus research. Virology, 519, 74–76 (2018).
   PubMed Web of Science ®Google Scholar
• Novakovic D , ChengATL, ZurynskiYet al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J. Infect. Dis., 217(2), 208–212 (2018).
   PubMed Web of Science ®Google Scholar
• Ushikai M , FujiyoshiT, KonoMet al. Detection and cloning of human papillomavirus DNA associated with recurrent respiratory papillomatosis in Thailand. Jpn J. Cancer Res., 85(7), 699–703 (1994).
   PubMedGoogle Scholar
• Komloš KF , KocjanBJ, KošorokPet al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J. Med. Virol., 84(8), 1233–1241 (2012).
   PubMed Web of Science ®Google Scholar
• Seedat RY , ThukaneM, JansenAC, RossouwI, GoedhalsD, BurtFJ. HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa. Int. J. Pediatr. Otorhinolaryngol., 74(3), 255–259 (2010).
   PubMed Web of Science ®Google Scholar
• Tjon Pian Gi REA , SanGiorgi MRM, Slagter-MenkemaLet al. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head Neck, 37, 1625–1632 (2015).
   PubMed Web of Science ®Google Scholar
• Sanchez GI , JaramilloR, CuelloGet al. Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia. Head Neck, 35(2), 229–234 (2013).
   PubMed Web of Science ®Google Scholar
• Jelen MM , ChenZ, KocjanBJet al. Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. J. Virol., 88(13), 7307–7316 (2014).
   PubMed Web of Science ®Google Scholar
• Jelen MM , ChenZ, KocjanBJet al. Global genomic diversity of human papillomavirus 11 based on 433 isolates and 78 complete genome sequences. J. Virol., 90(11), 5503–5513 (2016).
   PubMed Web of Science ®Google Scholar
• Clifford GM , TenetV, GeorgesDet al. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Res., 7, 67–74 (2019).
   PubMed Web of Science ®Google Scholar
• Seedat RY , CombrinckCE, BesterPA, LeeJY, BurtFJ. Determination of the complete genome and functional analysis of HPV6 isolate VBD19/10 from a patient with aggressive recurrent respiratory papillomatosis. Epidemiol. Infect., 144(10), 2128–2135 (2016).
   PubMed Web of Science ®Google Scholar
• Nagy Z , PethőZ, KardosG, MajorT, SzűcsA, SzarkaK. Effect of E2 and long control region polymorphisms on disease severity in human papillomavirus type 11 mediated mucosal disease: protein modelling and functional analysis. Infect. Genet. Evol., 93, 104948 (2021).
   PubMed Web of Science ®Google Scholar
• Sichero L , FerreiraS, LópezRVMet al. Prevalence of human papillomavirus 6 and 11 variants in recurrent respiratory papillomatosis. J. Med. Virol., 93(6), 3835–3840 (2021).
   PubMed Web of Science ®Google Scholar
• Lindeberg H , ElbrøndO. Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965–1984. Clin. Otolaryngol. Allied Sci., 15(2), 125–131 (1990).
   PubMed Web of Science ®Google Scholar
• Omland T , AkreH, VårdalM, BrøndboK. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope, 122(7), 1595–1599 (2012).
   PubMed Web of Science ®Google Scholar
• Bomholt A . Juvenile laryngeal papillomatosis. An epidemiological study from the Copenhagen region. Acta Otolaryngol. (Stockh.), 105(3–4), 367–371 (1988).
   PubMed Web of Science ®Google Scholar
• Silverberg MJ , ThorsenP, LindebergH, Ahdieh-GrantL, ShahKV. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch. Otolaryngol. Head Neck Surg., 130(6), 711–716 (2004).
   PubMedGoogle Scholar
• Derkay CS . Task Force on recurrent respiratory papillomas: a preliminary report. Arch. Otolaryngol. Head Neck Surg., 121(12), 1386–1391 (1995).
   PubMedGoogle Scholar
• Armstrong LR , PrestonEJ, ReichertMet al. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin. Infect. Dis., 31(1), 107–109 (2000).
   PubMed Web of Science ®Google Scholar
• Marsico M , MehtaV, ChastekB, LiawKL, DerkayC. Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. Sex. Transm. Dis., 41(5), 300–305 (2014).
   PubMed Web of Science ®Google Scholar
• Campisi P , HawkesM, SimpsonK. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope, 120(6), 1233–1245 (2010).
   PubMed Web of Science ®Google Scholar
• Novakovic D , ChengATL, CopeDH, BrothertonJML. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study. Sex. Health, 7(3), 253–261 (2010).
   PubMed Web of Science ®Google Scholar
• Novakovic D , ChengATL, BaguleyKet al. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates. Laryngoscope, 126(12), 2827–2832 (2016).
   PubMed Web of Science ®Google Scholar
• Oh JK , ChoiHY, HanM, JungYS, LeeSJ, KiM. Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea. Epidemiol. Health, 43, e2021019 (2021).
   PubMed Web of Science ®Google Scholar
• Seedat RY . The incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in the Free State province of South Africa and Lesotho. Int. J. Pediatr. Otorhinolaryngol., 78(12), 2113–2115 (2014).
   PubMed Web of Science ®Google Scholar
• Baidoo KK , KitcherED. Recurrent respiratory papillomatosis: the Korle-Bu experience. Ghana Med. J., 46(1), 43–45 (2012).
   PubMedGoogle Scholar
• World Health Organization . ‘Global market study: HPV vaccines’ (2020). http://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module2/HPV_Global_Market_Study_Public_Summary-Nov2020.pdf
   Google Scholar
• Teutsch SM , NunezCA, MorrisAet al. Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2020. Commun. Dis. Intell., 45, (2021).
   Web of Science ®Google Scholar
• Meites E , StoneL, AmilingRet al. Significant declines in juvenile-onset recurrent respiratory papillomatosis following human papillomavirus (HPV) vaccine introduction in the United States. Clin. Infect. Dis., 73(5), 885–890 (2021).
   PubMed Web of Science ®Google Scholar
• San Giorgi MRM , SeedatRY, DikkersFG. Larynxpapilloom ondanks vaccinatie. Ned. Tijdschr. Geneeskd., 165, D5028 (2021).
   PubMedGoogle Scholar